Economic and medical evaluation of the screening of C hepatitis and non-A non-B non-C hepatitis on donated blood;EVALUATION MEDICO-ECONOMIQUE DU DEPISTAGE DES HEPATITES C ET NON-A NON-B NON-C SUR LES DONS DE SANG

Revue d'Epidemiologie et de Sante Publique

Volumn 44, Issue 1, 1996, Pages 66-79

  Vergnon, P ^a   Colin, C ^a   Jullien, A M ^b   Bory, E ^c   Excoffier, S ^a   Matillon, Y ^a   Trepo, C ^c  

^a HÔTEL DIEU   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c INSERM   (France)

Author keywords

C hepatitis; cost analysis; donors; non A non B hepatitis; screening

Indexed keywords

ARTICLE; BLOOD DONOR; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEPATITIS C; HEPATITIS NON A NON B; HUMAN; SCREENING TEST; ADULT; BLOOD BANK; DECISION TREE; ECONOMICS; FEMALE; FRANCE; HEPATITIS E; MALE; MASS SCREENING; PREVALENCE; SENSITIVITY AND SPECIFICITY; STANDARD;

ADULT; BLOOD BANKS; BLOOD DONORS; COST-BENEFIT ANALYSIS; DECISION TREES; FEMALE; FRANCE; HEPATITIS C; HEPATITIS E; HUMANS; MALE; MASS SCREENING; PREVALENCE; SENSITIVITY AND SPECIFICITY;

EID: 0029987887     PISSN: 03987620     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Micoud M. Rapport sur l'état de l'hépatite C en France. Direction générale de la Santé Ministère des Affaires Sociales Paris, 1992.
2. Salamon R, Lawson-Ayayi S, Salmi LR. Evaluation des risques liés aux transfusions sanguines dans les pays industrialisés. Rev Epidem Santé Publ 1994 ; 42 : 408-15.
3. Fleurette F, Durieux P. Prévention des hépatites non-A non-B post-transfusionnelles. Méd Scienc 1991 ; 7(7) : 689-96.
4. Salmi LR, Collet JP. Lecture critique des articles médicaux: VI. Champ d'application et limites. Rev Prat 1992 ; 42 : 477-9.
5. O'Brien BJ, Drummond MF, Labelle RJ, Willan A. In search of power and signifiance. Issues in the design and analysis of stochastic cost-effectiveness studies in health care. Med Care 1994 ; 32 : 150-63.
6. Donahue JG, Munoz A, Ness PM et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992 ; 327 : 36973.
7. Azar N, Valla D, Lunel F et al. Post-transfusional anti-HCV-negative, non-A, non-B hepatitis. (I) A prospective clinical and epidemiological survey. J Hepat 1993 ; 18 : 24-33.
8. Jullien AM, Couroucé AM, Massari V et al. Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission. Eur J Clin Microbiol Infect Dis 1993 ; 12 : 668-72.
9. Garson JA, Clewley JP, Simmonds P et al. Hepatitis C viraemia in United Kingdom blood donors. A multicentre study. Vox Sang 1992 ; 62 : 218-23.
10. Koziol DE, Holland PV, Alling DW et al. Antibody to hepatitis B care antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Int Med 1986 ; 104 : 488-94.
11. Reesink HW, Leentvarr-Kuypers A, Van Der Poel CL et al. Non-A non-B post-transfusion hepatitis in open heart surgery patients in the Netherlands : Preliminary results of a prospective study. In : Viral Hepatitis and Liver Disease edited by Zuckerman A.J. New York : Alan R. Liss Inc., 1988 ; 558-60.
12. Stevens CE, Aach RD, Hollinger FB et al. Hepatitis B virus antibody in blood donors and the occurrence of non-A non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med 1984 ; 101 : 733-8.
13. Aach RD, Stevens CE, Hollinger FB et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 1991 ; 325 : 1325-9.
14. Van der Poel CL, Reesink HW, Schaasberg W et al. Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet 1990 ; 10 : 558-60.
15. Barrera JM, Bruguera M, Ercilla G et al. Incidence of non-A non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers. Ann Intern Med 1991 ; 115 : 596-600.
16. Leon P, Lopez JA, Domingo C, Echevarria JM. Evaluation of laboratory assays for screening antibody to hepatitis C virus. Transfusion 1993 ; 33 : 268-70.
17. Kolho E, Naukkarinen R, Krusius T. Specificity and sensitivity of two second-generation ELISA tests in detecting hepatitis C antibodies in blood donors known to be reactive with a supplemental assay (letter). Vox Sang 1992 ; 63 : 158-60.
18. Van Der Poel CL, Bresters D, Reesink HW et al. Early antihepatitis C virus response with second-generation C200/C22 ELISA. Vox Sang 1992 ; 62 : 208-12.
19. Sugitani M, Inchauspé G, Shindo M, Prince AM. Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet 1992 ; 339 : 1018-9.
20. De Beenhauwer Verhaert H, Claeys H, Vennylen C. Confirmation of hepatitis C virus positive blood donors by immunoblotting and polymerase chain reaction. Vox Sang 1992 ; 63 : 198-203.
21. Pereira BJG, Milfford EL, Kirkman RL et al. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992 ; 327 : 910-15.
22. Perez P, Salmi LR. Performance des tests de dépistage des infections virales et sécurité des produits humains à usage thérapeutique : synthèse des meilleures données disponibles. Rapport pour la Direction Générale de la Santé. Bordeaux : Université de Bordeaux II 1994.
23. Wang JT, Wang TH, Lin JT, Sheu JC, Lee CZ, Chen DS. Improved serodiagnosis of post-transfusion hepatitis C virus infection by a second-generation immunoassay based on multiple recombinant antigens. Vox Sang 1992 ; 62 : 21-4.
24. Esteban JI, Gonzales A, Hernandez JM et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990 ; 323 : 1107-12.
25. Bresters D, Cuypers HT, Reesink HW et al. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus. Vox Sang 1992 ; 62 : 213-7.
26. Agence Française du Sang. Etat des prélèvements 1992 et historique 1991. La Gazette de la Transfusion 1994 ; 1.
27. Habibi B, Smilovici W. Rapport sur la prévention des hépatites post-transfusionnelles non-A non-B. Revue Française de Transfusion et Immuno-hématologie 1988 ; 31 : 537-85.
28. Weinstein MC, Fineberg HV. Clinical Decision Analysis. Philadelphia : Saunders Company, 1980 : 351.
29. Colin C, Delahaye F, Ecochard R et al. L'analyse de la décision médicale. Arch Mal Cœur 1993 ; 86 : 1597-603.
30. Doubilet P, Mc Neil B. Medical decision making. Med Care 1985 ; 23 : 648-62.
31. Matillon Y, Duneux P. L'évaluation médicale du concept à la pratique. Paris : Flammarion Médecine-Sciences 1994.
32. Alter HJ. Post-transfusion hepatitis : Clinical features risk and donnor testing. Prog Clin Biol Res 1985 ; 182 : 47-61.